Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Current Pharmaceutical Design|August 13, 2002
Development of IL-5 receptor antagonistsIain Uings, Murray McKinnonExperimental Lung Research|September 10, 2002
A murine model of cigarette smoke-induced pulmonary inflammation using intranasally administered smoke-conditioned mediumLaura M Miller, W Michael Foster, Donna M Dambach, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Phosphodiesterase 7A-deficient mice have functional T cellsGuchen Yang, Kim W McIntyre, Robert M Townsend, et al.Bioorganic & Medicinal Chemistry Letters|March 11, 2009
Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferationJunqing Guo, Andrew Watson, James Kempson, et al.Bioorganic & Medicinal Chemistry Letters|April 13, 2013
Synthesis and evaluation of carbamoylmethylene linked prodrugs of BMS-582949, a clinical p38α inhibitorChunjian Liu, James Lin, Gerry Everlof, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2010
An LFA-1 (alphaLbeta2) small-molecule antagonist reduces inflammation and joint destruction in murine models of arthritisSuzanne J Suchard, Dawn K Stetsko, Patricia M Davis, et al.Bioorganic & Medicinal Chemistry Letters|February 13, 2007
Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffoldDharmpal S Dodd, Steven Sheriff, ChiehYing J Chang, et al.Bioorganic & Medicinal Chemistry Letters|February 26, 2008
Benzothiazole based inhibitors of p38alpha MAP kinaseChunjian Liu, James Lin, Sidney Pitt, et al.Bioorganic & Medicinal Chemistry Letters|March 25, 2008
Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitorsJagabandhu Das, Robert V Moquin, Sidney Pitt, et al.Bioorganic & Medicinal Chemistry Letters|August 1, 2007
Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffoldsT G Murali Dhar, Stephen T Wrobleski, Shuqun Lin, et al.Pageof 4